Company intelligence / Profile preview

TransAortic Medical

Morgan Hill, California, United Statestransaortic.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

TransAortic Medical develops the transShield Embolic Protection System, designed to reduce stroke risk by capturing and removing embolic debris during TAVR. Clinical studies in the field show that embolic protection can significantly reduce both all strokes and disabling strokes post-TAVR. The company's system claims full cerebral and peripheral vascular protection, unlike some competitors that only offer partial brain coverage. No direct clinical trial results for their own product are published yet.

Therapeutic areas: Cardiovascular
Modalities: DeviceEmbolic protection system
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on TransAortic Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TransAortic Medical.

Explore the full profile